FindTrial
Sign In

Research and application of functionality IgG4 and basophile activation test in specific immunotherapy

Research and application of functionality IgG4 and basophile activation test in specific immunotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-15006251
Enrollment
Unknown
Registered
2015-04-14
Start date
2015-04-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy

Interventions

specific immunotherapy group:specific immunotherapy
conventional treatment group:conventional treatment

Sponsors

The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Written informed consent obtained before entering the trial; 2. Male or female to be aged 5 to 55 years old; 3. With asthma and/or alleryg rhinitis; 4. With good compliance.

Exclusion criteria

Exclusion criteria: Patients with poor compliance.

Design outcomes

Primary

MeasureTime frame
basophile;specific IgG4;—

Countries

China

Contacts

Public ContactJing Li
lijing@gird.cn+86 020-34296151

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026